Cargando…
Compound Shuganjieyu Capsule on CYP450 Enzyme Activity
OBJECTIVE: To evaluate the potential drug-drug interactions of the Shuganjieyu capsule by establishing a Chronic Unpredictable Mild Stress (CUMS) depression model combined with the Cocktail probe substrate method. METHODS: The whole study was divided into the single-dose and multiple-dose groups. An...
Autores principales: | Tang, Yunqiu, Li, Yunxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584658/ https://www.ncbi.nlm.nih.gov/pubmed/36277901 http://dx.doi.org/10.1155/2022/3228738 |
Ejemplares similares
-
Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression
por: Fu, Jinhua, et al.
Publicado: (2014) -
Efficacy and Safety of Shuganjieyu Capsule Alone or in Combination with Other Antidepressants in the Treatment of Postpartum Depression: A Meta-Analysis
por: Wang, Lingning, et al.
Publicado: (2022) -
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
por: Wang, Hao, et al.
Publicado: (2020) -
Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats
por: Shi, Yong, et al.
Publicado: (2021) -
CYP2A13 Acts as the Main Metabolic CYP450s Enzyme for Activating Leonurine in Human Bronchial Epithelial Cells
por: Xu, Ting, et al.
Publicado: (2020)